Sec Form 4 Filing - VERU DENNISON T @ Brickell Biotech, Inc. - 2020-02-14

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person VERU DENNISON T 2. Issuer Name and Ticker or Trading Symbol Brickell Biotech, Inc. [ BBI] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) C/O BRICKELL BIOTECH, INC., 5777 CENTRAL AVENUE, SUITE 102 3. Date of Earliest Transaction (MM/DD/YY) 02/14/2020 (Street) BOULDER, CO80301 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 02/14/2020 M 3,973 A 954,878 I By Self due to Control over the Entity that holds Shares Common Stock 02/29/2020 M 787 A 955,665 I By Self due to Control over the Entity that holds Shares Common Stock 03/31/2020 M 787 A 956,452 I By Self due to Control over the Entity that holds Shares Common Stock 04/30/2020 M 787 A 957,239 I By Self due to Control over the Entity that holds Shares Common Stock 05/31/2020 M 787 A 958,026 I By Self due to Control over the Entity that holds Shares Common Stock 06/03/2020 A 19,642 ( 2 ) A $ 0 26,872 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Restricted Stock Units ( 1 ) 02/14/2020 M 3,973 ( 3 ) ( 3 ) Common Stock 3,973 $ 0 3,973 I By self due to Control over the Entity that holds RSUs Restricted Stock Units ( 1 ) 02/29/2020 M 787 ( 3 ) ( 3 ) Common Stock 787 $ 0 787 I By self due to Control over the Entity that holds RSUs Restricted Stock Units ( 1 ) 03/31/2020 M 787 ( 3 ) ( 3 ) Common Stock 787 $ 0 787 I By self due to Control over the Entity that holds RSUs Restricted Stock Units ( 1 ) 04/30/2020 M 787 ( 3 ) ( 3 ) Common Stock 787 $ 0 787 I By self due to Control over the Entity that holds RSUs Restricted Stock Units ( 1 ) 05/31/2020 M 787 ( 3 ) ( 3 ) Common Stock 787 $ 0 787 I By self due to Control over the Entity that holds RSUs Stock Option (right to buy) $ 1.12 06/03/2020 A 4,333 08/31/2020 06/03/2030 Common Stock 4,333 $ 0 4,333 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other VERU DENNISON T C/O BRICKELL BIOTECH, INC. 5777 CENTRAL AVENUE, SUITE 102 BOULDER, CO80301 X Signatures /s/ Christine G. Long, Attorney-in-Fact for Dennison T. Veru (power of attorney filed herewith) 06/05/2020 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Restricted stock units ("RSUs") converted into common stock on a one-for-one basis. ( 2 )Represents RSUs that are scheduled to vest on August 31, 2020 and will be settled in the form of one share of common stock for each restricted stock unit. ( 3 )These RSUs were granted on February 14, 2020 and vest in installments through August 31, 2020.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.